Pre-roll Market Size and Growth

Not long ago, pre-rolls were treated as a low-priority SKU. Dispensaries carried them because customers asked, not because anyone saw serious growth potential in a product that had a reputation for being low-grade and inconsistent. That picture has changed completely.

Pre-rolls are now the fastest-growing major product category in legal cannabis. They are pulling market share from flower, attracting both first-time buyers and long-time enthusiasts, and forcing brands to rethink how they build and staff their production operations. The data behind this shift is worth looking at closely.

The headline numbers: $4.1 billion and climbing

Pre-rolls brought in $4.1 billion in sales across tracked U.S. markets from January 2023 through mid-2024, with over 394 million units sold in that window. From June 2023 to June 2024, the category posted 11.89% year-over-year revenue growth, which was the highest rate of any major product format during that period.

For context: vape, edibles, and concentrates were either flat or down in dollar terms during the same stretch. Pre-rolls and flower were the only two major categories that actually grew revenue year over year. In a market where price compression and oversupply have squeezed margins across the board, that kind of growth is notable.

Monthly pre-roll revenues climbed from roughly $181 million in early 2023 to $257 million by mid-2024, a 42% increase in monthly run rate over about 18 months.

Market share: from 10% to nearly 16% in five years

The market share numbers tell an even more compelling story than raw revenue. In 2020, pre-rolls held just 9.8% of total cannabis product sales. By mid-2024, that number had climbed to 15.9%, and analysts expect it to push past 16% as newer adult-use markets continue to develop.

A six-point gain in market share over four years is not a blip. It reflects a sustained shift in consumer behavior, and nearly all of that share has come at flower's expense. Flower still leads in total revenue, but it has been losing ground consistently for several years.

In California, pre-roll unit sales have now surpassed traditional eighth-ounce flower packages. That is a real milestone. The largest regulated cannabis market in the world now sells more joints than jars of bud.

Why pre-rolls are winning: the convenience factor

The growth makes sense when you look at who is buying cannabis now. Smoking remains the most common consumption method, with about 74% of consumers reporting it as their primary approach. But the way people want to smoke has changed.

Pre-rolls eliminate the steps that many consumers find inconvenient or intimidating: grinding, rolling, storing loose flower. They are consistent, portable, and ready to use. For newer cannabis consumers, who represent a large share of the people entering the market as legalization spreads, a pre-roll from a licensed dispensary is a much easier starting point than buying flower and figuring out what to do with it.

At the same time, the category has shed its cheap reputation. Infused and premium pre-rolls have brought in experienced buyers who previously gravitated toward concentrates or top-shelf flower. Pre-rolls are not just a convenience item anymore. For a growing segment of the market, they are the preferred format.

The infused segment: the fastest-growing part of a fast-growing category

Within the pre-roll category, infused products are the standout performer. Infused pre-rolls combined flower with concentrates like live resin, hash rosin, kief, distillate, or diamonds, and the consumer response has been strong and sustained.

In 2019, infused pre-rolls held about 34.4% of the pre-roll market. By mid-2024, that figure had risen to 44.4%, and the segment accounted for over $1.75 billion in sales from 2023 through mid-2024 alone. In California, infused pre-rolls now represent 66% of all pre-roll sales by dollar value. In the market that arguably defined the modern pre-roll, traditional uninfused products are now the minority.

The consumer logic driving this is straightforward. As people spend more time in the legal cannabis market, they tend to seek out higher-potency products and more differentiated experiences. Infused formats deliver on both. They also give brands a legitimate basis for premium pricing, at least in markets where price competition has not yet eroded margins.

California's average infused pre-roll retails around $19.20. Michigan, which is a far more price-competitive market, sits closer to $10.23. Both figures are well above the $5 to $7 range where standard pre-rolls compete in mature markets.

Infused formats could account for 50% or more of total pre-roll category sales within the next few years. For brands deciding where to focus their SKU development, this is the segment worth building around.

Multi-packs: a quieter but significant shift

Multi-pack pre-rolls have not gotten as much attention as the infused trend, but they represent a meaningful structural change in how the category is bought and sold.

In 2018, multi-packs accounted for roughly 27.7% of U.S. pre-roll sales. By mid-2024, they had climbed to nearly 50% of the market, with unit sales up 43% over just 18 months. Canada, which tends to run a few years ahead of the U.S. in terms of market maturity, has already reached 85% multi-pack share.

The appeal spans different types of buyers. Value-oriented consumers like the per-unit economics. Regular users appreciate having a ready supply on hand. Social buyers like having something to share. For brands and operators, multi-packs also mean more brand impressions per transaction and more packaging real estate to tell a story.

A state-by-state look: where the market is strongest

Pre-roll dynamics vary significantly by market, and the geographic breakdown matters for any operator thinking about where to compete and how to price.

California leads in total dollar revenue, generating $734.5 million in pre-roll sales over the 12-month period ending mid-2024. Pre-rolls represent about 17% of the state's legal cannabis market. Average prices have dropped from $11.68 in 2022 to around $9.50 in late 2024, but unit demand has remained solid.

Michigan leads in unit volume by a wide margin. Consumers in the state purchased 94.6 million pre-rolls in the tracked period, nearly double California's 52.1 million units. The state's average item price of $5.57 is the lowest in the country, which reflects intense competition, but the unit volume makes Michigan one of the most important production markets in the U.S.

Massachusetts has the highest pre-roll market share of any tracked state at 19.2%, meaning close to one in five cannabis dollars in the state goes to pre-rolls. Michigan and New York are tied for second at 18.2%.

Maryland has been a growth story since launching adult-use sales in 2023, bringing in more than $135 million in pre-roll revenue through the first half of 2024. Missouri hit record pre-roll sales in mid-2024, with units up 37.8% over the start of the year.

Emerging markets like New York are still in early stages of building out their licensed retail infrastructure. New York has the highest average pre-roll item price in the country at $21.20, and early sales data shows the format capturing real market share as more stores open.

What Canada tells us about where the U.S. is headed

Canada legalized adult-use cannabis nationwide in 2018, which gives its market several more years of maturation than most U.S. states. The trajectory there offers a reasonable preview of what to expect as American markets age.

Pre-rolls overtook flower as Canada's top-grossing cannabis category in 2024, generating over $1.27 billion in revenue for the year. Flower's lead over pre-rolls had already shrunk from 4% in 2023 to just 0.25% in 2024 before pre-rolls moved ahead. Multi-packs, as noted, account for 85% of Canadian pre-roll sales.

If U.S. markets follow a similar path, and the early signs suggest they will, the current 15 to 16% national pre-roll market share has a meaningful runway ahead. Even the most mature U.S. markets, like Colorado, Washington, and Oregon, have seen their per-unit prices compress as competition increased, but they have also maintained the kind of sustained unit volume that keeps the category economically relevant.

What the data means for operators and manufacturers

Production volume is the baseline requirement. With 394 million units sold across tracked markets over 18 months, and those markets covering only a portion of total U.S. legal sales, the demand for consistent, high-volume production is real. Brands running manual or semi-automated operations are already hitting ceilings that their competitors are not.

Infused products are the defensible position. Standard pre-rolls face predictable price compression as markets mature and competition increases. Infused formats hold better margins, attract a more engaged buyer, and are growing faster within the category. That is where the long-term brand equity is being built.

New markets reward early movers. In California and Colorado, the market is crowded and price-sensitive. States that have recently launched adult-use programs still have room for brands to establish themselves before the shelves fill up. Michigan is a good case study: the brands that entered early and built production infrastructure to match demand are the ones that own the market today.

Consistency is what keeps shelf space. As pre-roll options have multiplied at dispensaries, retail buyers have become more selective. Brands that hold their placement are the ones delivering consistent weight, burn quality, and potency batch after batch. That outcome is a function of production quality as much as product quality.

The Bottom Line:

Pre-rolls have gone from a convenience add-on to a primary driver of cannabis retail sales, and the data shows that shift has been building steadily for five years. The $4.1 billion in tracked revenue, the 11.89% annual growth rate, the market share gain from 9.8% to nearly 16%, and the continued rise of infused formats all point in the same direction.

The brands in the best position right now are the ones that recognized this early and built operations to match. They invested in production infrastructure, developed infused SKU lineups, and put real attention into the consistency that dispensary buyers require. The brands still catching up are doing the same work now, but with less time and more competition.

The window is still open. But it gets smaller as more operators figure out the same things.